SOPHiA GENETICS
SOPH
29 hedge funds and large institutions have $167M invested in SOPHiA GENETICS in 2022 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 10 reducing their positions, and 10 closing their positions.
4.74% more ownership
Funds ownership: 29.15% → 33.89% (+4.7%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
9% less funds holding
Funds holding: 32 → 29 (-3)
20% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 10
30% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 10
36% less capital invested
Capital invested by funds: $262M → $167M (-$95M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BPC
Banque Pictet & Cie
Geneva 73,
Switzerland
|
+$23.6M |
| 2 |
PVI
Pura Vida Investments
New York
|
+$9.32M |
| 3 |
BPCE
Bank Pictet & Cie (Europe)
Frankfurt Am Main,
Germany
|
+$2.56M |
| 4 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$810K |
| 5 |
BPCA
Bank Pictet & Cie (Asia)
Singapore
|
+$724K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LOAMS
Lombard Odier Asset Management (Switzerland)
Petit-Lancy,
Switzerland
|
-$2.07M |
| 2 |
RI
RTW Investments
New York
|
-$825K |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$703K |
| 4 |
Millennium Management
New York
|
-$544K |
| 5 |
PAMS
Pictet Asset Management (Switzerland)
Geneva 73,
Switzerland
|
-$247K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Osaic Holdings
Scottsdale,
Arizona
| $3K | -$674 | -60 | -14% |
|
|
CCA
27
Column Capital Advisors
Indianapolis,
Indiana
| $2K | – | – | – |
|
28
AssetMark Inc
Concord,
California
| $2K | +$2.36K | +210 | New |
|
|
LOAMS
29
Lombard Odier Asset Management (Switzerland)
Petit-Lancy,
Switzerland
| – | -$2.07M | -146,844 | Closed |
|
30
Citadel Advisors
Miami,
Florida
| – | -$200K | -14,194 | Closed |
|
31
Zurich Cantonal Bank
Zurich,
Switzerland
| – | -$137K | -9,711 | Closed |
|
|
CLOS
32
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
| – | -$113K | -7,975 | Closed |
|
33
Northern Trust
Chicago,
Illinois
| – | -$89K | -6,311 | Closed |
|
|
HIIFS
34
Harel Insurance Investments & Financial Services
Ramat Gan,
Israel
| – | -$20K | -1,520 | Closed |
|
|
TRCT
35
Tower Research Capital (TRC)
New York
| – | -$8K | -600 | Closed |
|
|
TCWM
36
Total Clarity Wealth Management
St. Charles,
Illinois
| – | -$8K | -539 | Closed |
|
37
JP Morgan Chase
New York
| – | -$5K | -343 | Closed |
|
38
Citigroup
New York
| – | -$1K | -98 | Closed |
|
|
T
39
TCWP
Beachwood,
Ohio
| – | +$337 | +30 | New |
|
SOPH Hedge Fund Activity: Q1 2022 in Review
29 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in SOPHiA GENETICS (SOPH) for Q1 2022, worth a combined $167M — down 36% from $262M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of SOPH and 7 opened new positions — a net loss of 3 holders — while 10 trimmed existing stakes and 8 added.
The largest buyer was Banque Pictet & Cie, opening a new position worth an estimated $23.6M. The largest seller was Lombard Odier Asset Management (Switzerland), exiting entirely with an estimated $2.07M sold.
- 29 institutional investors held SOPHiA GENETICS (SOPH) as of Q1 2022, down from 32 in Q4 2021.
- Funds reported $167M of SOPHiA GENETICS stock for Q1 2022, down 36% quarter-over-quarter.
- 7 funds opened new SOPHiA GENETICS positions in Q1 2022 and 10 closed out, a net change of -3 holders.
- The largest SOPHiA GENETICS buyer in Q1 2022 was Banque Pictet & Cie, an estimated $23.6M added.
- The largest SOPHiA GENETICS seller in Q1 2022 was Lombard Odier Asset Management (Switzerland), an estimated $2.07M sold.
Based on aggregated 13F filings for Q1 2022.